Oppenheimer & Co’s Vicor VICR Stock Holding History

Oppenheimer & Co’s Portfolio VICR Stock Details VICR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Sell	4,579 -68	-1%	-$18.6K	0.02%	697
2026 Q1	$748K	Buy	4,647 +2,273	+96%	+$376K	0.01%	1007
2025 Q4	$260K	Buy	+2,374	New	+$202K	﹤0.01%	1325

Other funds holding VICR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Oppenheimer & Co's VICR Position: Q2 2026 in Review

Oppenheimer & Co reduced its Vicor (VICR) stake by 1.5% in Q2 2026, selling an estimated $18.6K and leaving 4,579 shares worth $1.74M. The position accounts for 0.02% of the portfolio, ranked #697.

Oppenheimer & Co first reported a position in VICR in Q4 2025 and has held it in 3 quarters since. 515 funds tracked by Wall St. Rank hold VICR as of Q2 2026.

Oppenheimer & Co held 4,579 shares of Vicor worth $1.74M as of Q2 2026.
Oppenheimer & Co sold 68 Vicor shares in Q2 2026, an estimated $18.6K.
Vicor made up 0.02% of Oppenheimer & Co's portfolio in Q2 2026, its #697 holding.
Oppenheimer & Co first reported a position in Vicor in Q4 2025 and has held it in 3 quarters since.
515 funds tracked by Wall St. Rank held Vicor as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.